|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2008-5-16
|
|
pubmed:abstractText |
The purpose of this study was to investigate expression and epigenetic regulation of CD9 in multiple myeloma (MM) cells during disease progression.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD9,
http://linkedlifedata.com/resource/pubmed/chemical/CD9 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Cd9 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Histone Deacetylases,
http://linkedlifedata.com/resource/pubmed/chemical/Histones,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxamic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/LBH589,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:AsosinghKewalK,
pubmed-author:AtadjaPeterP,
pubmed-author:BosTomas JanTJ,
pubmed-author:CoiteuxValérieV,
pubmed-author:De BruyneElkeE,
pubmed-author:LeleuXavierX,
pubmed-author:MenuElineE,
pubmed-author:ThielemansKrisK,
pubmed-author:Van CampBenB,
pubmed-author:Van RietIvanI,
pubmed-author:Van ValckenborghElsE,
pubmed-author:Vande BroekIsabelleI,
pubmed-author:VanderkerkenKarinK
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2918-26
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:18483358-Adult,
pubmed-meshheading:18483358-Aged,
pubmed-meshheading:18483358-Aged, 80 and over,
pubmed-meshheading:18483358-Animals,
pubmed-meshheading:18483358-Antigens, CD,
pubmed-meshheading:18483358-Antigens, CD9,
pubmed-meshheading:18483358-Cytotoxicity, Immunologic,
pubmed-meshheading:18483358-DNA Methylation,
pubmed-meshheading:18483358-Disease Progression,
pubmed-meshheading:18483358-Enzyme Inhibitors,
pubmed-meshheading:18483358-Epigenesis, Genetic,
pubmed-meshheading:18483358-Female,
pubmed-meshheading:18483358-Flow Cytometry,
pubmed-meshheading:18483358-Histone Deacetylases,
pubmed-meshheading:18483358-Histones,
pubmed-meshheading:18483358-Humans,
pubmed-meshheading:18483358-Hydroxamic Acids,
pubmed-meshheading:18483358-Immunophenotyping,
pubmed-meshheading:18483358-Kaplan-Meier Estimate,
pubmed-meshheading:18483358-Killer Cells, Natural,
pubmed-meshheading:18483358-Male,
pubmed-meshheading:18483358-Membrane Glycoproteins,
pubmed-meshheading:18483358-Mice,
pubmed-meshheading:18483358-Middle Aged,
pubmed-meshheading:18483358-Multiple Myeloma,
pubmed-meshheading:18483358-Retrospective Studies,
pubmed-meshheading:18483358-Reverse Transcriptase Polymerase Chain Reaction
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Epigenetic silencing of the tetraspanin CD9 during disease progression in multiple myeloma cells and correlation with survival.
|
|
pubmed:affiliation |
Department of Hematology and Immunology, Vrije Universiteit Brussel, Brussels, Belgium.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
